Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Global Healthcare Today.
Press releases published on May 22, 2025
Europe Radiotherapy Patient Positioning Market to Reach USD 196.1 Million by 2034, Growing at 3.8% CAGR
EIN Presswire
·
May 22, 2025
Europe radiotherapy patient positioning market grows as precision in cancer care rises, driven by increasing demand for accurate treatment NEWARK, DE, UNITED STATES, May 22, 2025 /EINPresswire.com/ -- The Europe sales of radiotherapy patient positioning …
Hematology Diagnostics Market CAGR 5.57 % with Growth USD 13641.41 Billion by 2033
EIN Presswire
·
May 22, 2025
Hematology Diagnostics market size is projected at USD 8841.69 M in 2025 and is anticipated to reach 13641.41 M by 2033, registering a CAGR of 5.57%. PUNE, MAHARASHTRA, INDIA, May 22, 2025 /EINPresswire.com/ -- "Hematology Diagnostics Market" research …
New Report Examines the Impact of Disinformation on Public Health Outcomes
EIN Presswire
·
May 22, 2025
MANILA, PHILIPPINES, May 22, 2025 /EINPresswire.com/ -- In an era of widespread access to information, the growing influence of disinformation presents complex challenges for public health. A new analysis, The Silent Threat: How Disinformation Harms …
New Online Resource Aims to Help Raise Awareness of the Challenges Faced by Cancer Survivors
EIN Presswire
·
May 22, 2025
The NCSD Foundation has launched a toolkit designed to increase understanding of cancer survivorship challenges and promote National Cancer Survivors Day®. FRANKLIN, TN, UNITED STATES, May 22, 2025 /EINPresswire.com/ -- Ahead of the 38th annual National …
China’s Version of Inspiren: Non-Intrusive, Wear-Free, Proactive Care for Aging at Home
EIN Presswire
·
May 22, 2025
BEIJING, CHINA, May 22, 2025 /EINPresswire.com/ -- The 11th China International Senior Service Industry Expo opened today at the Beijing International Convention Center, presided over by Zhang Meiy ing，Vice Chairwoman of the 11th National Committee of …
A New Step Forward in Biologic Vision Enhancement - Transform™ now launched in Canada
EIN Presswire
·
May 22, 2025
Allotex receives Canadian clearance and launches Transform™, a human collagen-based implant enabling surgeons to offer natural vision correction. CANADA, May 22, 2025 /EINPresswire.com/ -- Allotex, a global innovator in biologic vision technologies, …
Soleno Therapeutics Announces Submission and EMA Validation of Marketing Authorization Application for Diazoxide Choline Prolonged-Release Tablets for the Treatment of Hyperphagia in Patients with Prader-Willi Syndrome
GlobeNewswire
·
May 22, 2025
REDWOOD CITY, Calif., May 22, 2025 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (Soleno) (NASDAQ: SLNO), a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases, today announced that Soleno’s Marketing Authorization …
Iovance Announces Five-year Results of Amtagvi® (lifileucel) in Patients with Advanced Melanoma at ASCO Annual Meeting
GlobeNewswire
·
May 22, 2025
One-time Amtagvi Treatment Demonstrated Durable Responses and a Five-year Overall Survival Rate of 20% Five-year Follow Up is Unprecedented for Any Therapy in Patients with Advanced Melanoma Previously Treated with Immune Checkpoint Inhibitor SAN CARLOS, …
INDIGO Biosciences Launches Stable Reporter Cell Lines for Drug Discovery and Toxicology Research
EIN Presswire
·
May 22, 2025
STATE COLLEGE, PA, UNITED STATES, May 22, 2025 /EINPresswire.com/ -- INDIGO Biosciences, a global leader in cell-based assay solutions, announced today a significant expansion to its product portfolio with the launch of proprietary Stable Reporter Cell …
Merus’ Petosemtamab with Pembrolizumab Interim Data Demonstrates Robust Efficacy and Durability in 1L PD-L1+ r/m HNSCC
GlobeNewswire
·
May 22, 2025
- 63% response rate observed among 43 evaluable patients - 79% overall survival rate at 12-months; 9 months median progression-free survival - Conference Call on Thursday, May 22 at 5:30 p.m. ET UTRECHT, The Netherlands and CAMBRIDGE, Mass., May 22, …
Kura Oncology and Kyowa Kirin Announce Pivotal Monotherapy Data for Ziftomenib in Oral Presentation at the 2025 ASCO Annual Meeting
GlobeNewswire
·
May 22, 2025
– Results from KOMET-001 registration-directed trial of ziftomenib in R/R NPM1-m AML patients selected for oral presentation on Monday, June 2nd – – Encore presentation planned at EHA 2025 Congress – – Kura Oncology to host virtual investor event at 7:30pm …
Legend Biotech Announces New Oncologic & Hematologic Therapeutic Developments at ASCO, EHA, and ASGCT
GlobeNewswire
·
May 22, 2025
An oral presentation at ASCO …
Menarini Group Presents Updated Data Underscoring the Combinability of Elacestrant (ORSERDU®) in Patients with ER+, HER2- Metastatic Breast Cancer (mBC) at the ASCO 2025 Annual Meeting
GlobeNewswire
·
May 22, 2025
Preliminary efficacy analysis from the elacestrant plus everolimus and ribociclib cohorts of the ELEVATE study, along with updated safety data from additional cohorts of elacestrant plus targeted therapy combination arms, will be presented. These data …
Chinese technology deal speeds up Pakistan's pharma production
EIN Presswire
·
May 22, 2025
SHEIKHUPURA, PAKISTAN, May 22, 2025 /EINPresswire.com/ -- Pharmaceutical machinery provider Xin Weisheng is streamlining Pakistan’s manufacturing of healthcare products with its unique processing equipment. Xin Weisheng technology is enabling …
Boehringer Ingelheim to present early clinical evidence of innate immune modulation and anti-tumor activity via SIRPα blockade in two ongoing trials at ASCO 2025
GlobeNewswire
·
May 22, 2025
· BI 765063 in combination with programmed cell death-1 (PD1) inhibitor antibody ezabenlimab + cetuximab demonstrated a well-tolerated safety profile and potentially promising efficacy signals as second-line treatment in patients with recurrent/ …
Actuate Therapeutics Announces Details for 2025 ASCO Annual Meeting Presentation on Topline Elraglusib Phase 2 Data in First-Line Treatment of Metastatic Pancreatic Cancer
GlobeNewswire
·
May 22, 2025
Phase 2 (Actuate-1801 Part 3B) trial topline results meet primary endpoint of improved survival in previously untreated patients with metastatic pancreatic ductal adenocarcinoma (mPDAC) Oral presentation at the American Society of Clinical Oncology (ASCO) …
Adagene Announces Updated Data from Phase 1b/2 Study of Muzastotug (ADG126) in Combination with KEYTRUDA® (pembrolizumab) in Colorectal Cancer at the American Society of Clinical Oncology (ASCO) Annual Meeting
GlobeNewswire
·
May 22, 2025
CTLA-4 inhibitor ADG126 can be dosed at 20 mg/kg Q6W in combination with pembrolizumab with <20% Grade 3 adverse events In combination with pembrolizumab, ADG126 showed a 29% confirmed overall response rate (ORR) in microsatellite stable colorectal cancer …
Avidicure to Present Preclinical Data from Lead TROP2-targeting Multifunctional Antibody Program at the 2025 American Society of Clinical Oncology Annual Meeting
GlobeNewswire
·
May 22, 2025
AMSTERDAM, May 22, 2025 (GLOBE NEWSWIRE) -- Avidicure, a biotechnology company pioneering an entirely new dual agonistic, multifunctional antibody modality with broad applicability in oncology, today announced its upcoming presentation at the 2025 American …
Candel Therapeutics Presents Positive Phase 3 CAN-2409 Results in Localized Prostate Cancer at ASCO 2025
GlobeNewswire
·
May 22, 2025
NEEDHAM, Mass., May 22, 2025 (GLOBE NEWSWIRE) -- Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical stage biopharmaceutical company focused on developing multimodal biological immunotherapies to help patients fight cancer, today …
Biodesix Announces New Data on the VeriStrat® Test to be Presented at the 2025 ASCO Annual Meeting
GlobeNewswire
·
May 22, 2025
LOUISVILLE, Colo., May 22, 2025 (GLOBE NEWSWIRE) -- Biodesix, Inc. (Nasdaq: BDSX), a leading diagnostic solutions company, announced today that new data will be presented at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, …